On Friday, March 6^th, 2020, during the "Sibiu Dermatology Days" Conference, the symposium "GSEBA®: New generation anti-inflammatory for the treatment of dermatitis and relapse prophylaxis” took place, held by University Professor Dr. Maria ROTARU, head of the Dermatology Clinical Department of the Sibiu County Emergency Clinical Hospital and head of the Subject Department at the Faculty of Medicine within “Lucian Blaga” University of Medicine and Pharmacy in Sibiu.

During the event, the latest topical preparation was presented, namely GSEBA^®, based on GSH-C4 0.4%, Hyaluronic Acid 0.25% and Tocopherol for the treatment of dermatitis of various etiology and prophylaxis of relapses, and the efficiency and safety of the product was evaluated in patients with mild, moderate and severe seborrheic dermatitis of the face. Treatment proved to be well tolerated by all patients, no adverse effects were reported, and evaluation of patients 2 months after completion of treatment showed that no patient relapsed after treatment.

GSEBA^® is a new anti-inflammatory agent with a unique mechanism of action and a higher safety profile, being safe to use in children under 2 years. The product is available in pharmacies across the country.